“Let us shoulder the heavy responsibility of innovative development.”
Category:
发布时间:2020-01-20
【概要描述】
On the afternoon of January 19, on the eve of the upcoming Spring Festival, the medium-sized conference room of the Company’s Pharmaceutical Research Institute was filled with the fragrant aroma of tea and a warm, welcoming atmosphere as the company held a symposium for its scientific and technical personnel to celebrate the New Year. Su Xuejun, Chairman of the Board, and Wu Hengyao, General Manager, joined scientists and engineers from the front lines of production and research in a lively discussion about future development, warmly welcoming the Spring Festival.
On the afternoon of January 19, on the eve of the upcoming Spring Festival, the medium-sized conference room of the Company’s Pharmaceutical Research Institute was filled with the sweet aroma of fruit and a warm, welcoming atmosphere as the company held a symposium for its scientific and technical personnel to celebrate the New Year. Chairman Su Xuejun and General Manager Wu Hengyao joined scientists and engineers from the front lines of production and research to discuss the company’s development and warmly welcome the Spring Festival.
Dr. Ma Yongqing, who had just joined Sihua Pharmaceutical, opened the floor as soon as he took his seat: “At the end of last year, General Manager Qu personally assumed leadership and spearheaded a major overhaul of our R&D management system. In little more than a month, the newly established ‘Four Institutes, Two Centers, and Five Departments’ operating framework has been running efficiently, with smoother workflows and a growing emphasis on project execution and accelerated progress across the institute. The internal momentum for innovation is becoming increasingly evident, and everyone is highly confident that we can catch up with and surpass industry leaders—so let’s rise to the challenge and shoulder the heavy responsibility of driving innovative development!”
Taking up her remarks, Chairman Su Xuejun said with deep conviction: “Pursuing innovation is to secure the future. The key to driving innovation lies in mobilizing people—the primary and most dynamic factor. Once the institutional mechanisms are streamlined, responsibilities are clearly defined, and morale is high, the changes we have seen in just over a month have given us the confidence and momentum to leapfrog and catch up!”
As soon as the topic was raised, everyone eagerly shared their views on corporate innovation, creating a lively and spirited atmosphere. The Spring Welcome Symposium effectively turned into a “Council of Zhuge Liangs” for brainstorming innovative solutions.
“During late spring and summer, high air humidity can adversely affect material drying; it is recommended to install additional humidity monitoring equipment to closely track humidity levels and product drying performance.” “Azithromycin is Guolong’s primary driver of profit growth this year. Enhancing the quality and yield of all azithromycin intermediates is crucial for strengthening our market competitiveness. To this end, we must collaborate with pilot-scale researchers at the Research Institute to systematically explore and optimize the manufacturing process…”
With a focus on practical matters and candid advice, company leaders—including Chairman Su Xuejun and General Manager Wu Hengyao—regularly engaged in dialogue with technical personnel from the production front lines, carefully listening to their concerns and meticulously recording their views and suggestions in notebooks.
To implement the innovation-driven development strategy, it is imperative to firmly grasp technological innovation as the “key lever,” with a focus on mechanisms for incentivizing scientific and technological advancement, the recruitment and cultivation of talent teams, the identification of distinctive areas of innovation, the evaluation of generic drug consistency, and the research and development of innovative projects and products. In these areas, scientific and technical personnel have actively offered suggestions and proposals.
“Scientific research must be forward-looking; as work progresses, we must promptly consider how to transition laboratory research into industrial applications, striving to strike a balance among speed, quality, scientific risk, and cost.” “We should strengthen seamless collaboration with major universities to infuse fresh talent and expertise into R&D.” “Breaking down technological barriers is a long-term endeavor; we must address, step by step, the technical challenges that impede project progress, which requires innovative thinking.”…
“Scientific and technological personnel are the main force driving enterprise development. The company will vigorously foster an environment and culture that respects knowledge, values innovation, and honors talent, and will employ a variety of measures to encourage continuous innovation among our R&D staff. We hope that all our scientific and technological professionals will always bear in mind their responsibilities and mission as members of the company, dare to step up and take responsibility, stay committed to their posts, and boldly put theory into practice—thereby contributing to the company’s growth while realizing their own personal aspirations. On the occasion of the upcoming Spring Festival, I would like to express my heartfelt gratitude to all our R&D staff for their hard work over the past year, and wish you all outstanding achievements and even greater success in the new year.” These were the sincere words of Chairman Su Xuejun to the company’s entire team of scientific and technological professionals.
As the city lights begin to glow, the neon signs of the “Shi Si Yao Pharmaceutical Research Institute” shine brilliantly, heralding the arrival of spring for Sihua Pharmaceutical Technology.
Keywords:
Recommended News
SERVICE HOTLINE
Address: Shimen Building, No. 8 Xingye Street, Shijiazhuang Economic and Technological Development Zone
Tel.: +86-311-67167130
Email: office@sjzsiyao.com
Mobile site
E code
Non-Commercial (Filing) – 2025-0091